Markets › United States › NAS › ALNY

Alnylam Pharmaceuticals Inc

NAS:ALNYHealthcareNASDAQ:NBINASDAQ:NQUSMG

$233.29+0.63%At closeAt close · Tue 20 Oct · ≈ AED 856.76 · Market cap $31.22B · Next earnings Thu 29 Oct

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-07-30	1.63	1.21	−26.0%	1,322.1	1,290.9	−2.4%
2026-04-30	0.87	1.51	+73.2%	1,115.5	1,167.2	+4.6%
2026-02-12	1.16	0.82	−29.3%	1,149.1	1,097.0	−4.5%
2025-10-30	0.56	2.90	+416.9%	959.4	1,249.0	+30.2%
2025-07-31	−0.54	0.32	+158.9%	662.9	773.7	+16.7%
2025-05-01	−0.89	−0.01	+98.9%	585.1	594.2	+1.5%
2025-02-13	−0.62	0.06	+109.7%	582.6	593.2	+1.8%
2024-10-31	−0.92	−0.50	+45.5%	532.9	500.9	−6.0%
2024-08-01	−1.07	0.56	+152.3%	447.2	659.8	+47.5%
2024-05-02	−1.12	−0.16	+85.7%	428.0	494.3	+15.5%
2024-02-15	−1.20	−1.10	+8.3%	442.9	439.7	−0.7%
2023-11-02	−1.34	1.15	+185.8%	401.0	750.5	+87.2%